Recent News

By Category: Research

IDRI and Medicago to Present Data on H5N1 Vaccine at the World Vaccine

(InfectionControlToday) The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and virus-like particles (VLPs), announce that they will be presenting positive Read More »

April 10, 2013
| Filed under North America, Countermeasures, and Research
Share

Malawi Joins Biological Weapons Convention

Malawi has become a full member to the Biological Weapons Convention, a senior U.S. diplomat said on Tuesday. "Delighted that Malawi has formally acceded to the Biological Weapons Convention," Laura Kennedy, the Obama administration's special envoy for BWC issue, said in a Twitter message. The African nation signed the accord in 1972. That pact, which Read More »

April 10, 2013
| Filed under Research
Share

Scientists use nature against nature to develop an antibiotic with reduced resistance

(Rockefeller University) A new broad range antibiotic has been found to kill a wide range of bacteria, including drug-resistant Staphylococcus (MRSA) bacteria that do not respond to traditional drugs, in mice. The antibiotic, Epimerox, targets weaknesses in bacteria that have long been exploited by viruses that attack them, known as phage, and promises to avoid Read More »

April 10, 2013
| Filed under Research
Share

DNDi welcomes the Global Health Innovative Technology Fund (GHIT)

(EurekAlert) The Drugs for Neglected Diseases initiative (DNDi), based in Geneva, Switzerland, and DNDi Japan, based in Tokyo, welcome the launch of the Global Health Innovative Technology Fund (GHIT), an initiative supported by the Japanese government, several Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation.

April 9, 2013
| Filed under Asia/Pacific, Policy & Initiatives, and Research
Share

Local scientists developing tests for vaccines against bioterror threats

(OrlandoSentinel) In their cold, sterile labs near Orlando, some local scientists are creating a hot commodity — biological replicas of the human immune system — that could play a role in saving the planet from a pandemic. That’s one of the goals, at least, of the work at Sanofi Pasteur VaxDesign Corp., the Central Florida Read More »